Sanofi-Aventis, P&G To Continue Actonel Collaboration
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies’ new agreement covers R&D and commercial efforts supporting the osteoporosis therapy, Sanofi-Aventis says. Procter & Gamble also will co-promote risedronate in “additional territories.”